Sign in

Filings

Finds words inside filing documents. Searching Werewolf Therapeutics, Inc.'s filings · 33 documents indexed.

12 documents · 48 matches

  1. HOWL Werewolf Therapeutics, Inc. 10-Q 2025-11-04

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    going concern for at least twelve months from the date these condensed consolidated financial statements are issued in this Form
    10 matches in this document

  2. HOWL Werewolf Therapeutics, Inc. 10-K 2026-03-27

    Item 16. Form 10-K Summary

    going concern. As discussed in Note 2 to the financial statements, the Company has suffered recurring losses from operations, has limited
    11 matches in this document

  3. HOWL Werewolf Therapeutics, Inc. 10-Q 2026-07-31

    Item 1 · Note 2. Strategic Review and Liquidity

    going concern for at least twelve months from the date these condensed consolidated financial statements are issued in this Quarterly
    10 matches in this document

  4. HOWL Werewolf Therapeutics, Inc. 10-Q 2026-05-07

    Item 1 · Note 2. Strategic Review and Liquidity

    going concern for at least twelve months from the date these condensed consolidated financial statements are issued in this Quarterly
    9 matches in this document

  5. HOWL Werewolf Therapeutics, Inc. 8-K 2026-07-31

    going concern; as well as the risks and uncertainties identified in the “Risk Factors” section of the Company’s most
    1 match in this document

  6. HOWL Werewolf Therapeutics, Inc. 8-K 2026-07-31

    Item 9.01. Financial Statements and Exhibits.

    going concern; as well as the risks and uncertainties identified in the “Risk Factors” section of the Company’s most
    1 match in this document

  7. HOWL Werewolf Therapeutics, Inc. 8-K 2026-05-07

    going concern; as well as the risks and uncertainties identified in the “Risk Factors” section of the Company’s most
    1 match in this document

  8. HOWL Werewolf Therapeutics, Inc. 8-K 2026-05-07

    Item 9.01. Financial Statements and Exhibits.

    going concern; as well as the risks and uncertainties identified in the “Risk Factors” section of the Company’s most
    1 match in this document

  9. HOWL Werewolf Therapeutics, Inc. 8-K 2026-03-27

    going concern; as well as the risks and uncertainties identified in the “Risk Factors” section of the Company’s most
    1 match in this document

  10. HOWL Werewolf Therapeutics, Inc. 8-K 2026-03-27

    Item 9.01. Financial Statements and Exhibits.

    going concern; as well as the risks and uncertainties identified in the “Risk Factors” section of the Company’s most
    1 match in this document

  11. HOWL Werewolf Therapeutics, Inc. 8-K 2025-11-04

    going concern; as well as the risks and uncertainties identified in the “Risk Factors” section of the Company’s most
    1 match in this document

  12. HOWL Werewolf Therapeutics, Inc. 8-K 2025-11-04

    Item 9.01. Financial Statements and Exhibits.

    going concern; as well as the risks and uncertainties identified in the “Risk Factors” section of the Company’s most
    1 match in this document

Page 1 of 1 · 12 documents